WntRx Pharmaceuticals
PrivateLast Round
Accelerator
Feb 29, 2016
Total Funding Raised
$1.5M
Company Overview
WntRx Pharmaceuticals is a biotechnology company that develops non-toxic, oncogenic-specific Wnt pathway inhibitors for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WntRx Pharmaceuticals Comparables
Compare WntRx Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapience Therapeutics | 86% | |
| StemSynergy Therapeutics, Inc. | 81% | |
| Iterion Therapeutics | 79% |
WntRx Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 29, 2016 | ||||
| Accelerator | Sep 1, 2015 | ||||
| Seed | Jul 1, 2015 | ||||
| Accelerator | Jul 1, 2014 | ||||
| Angel | May 1, 2014 |
WntRx Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Labs | Accelerator |
| TSV Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 29, 2016
Raised an Accelerator round with MassBio and MassCONNECT.
- Jul 1, 2014
Received funding from LabCentral.
WntRx Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about WntRx Pharmaceuticals's valuation, stock price, and market status.
Is WntRx Pharmaceuticals a public or private company?
WntRx Pharmaceuticals is a private company.
What is the current stock price of WntRx Pharmaceuticals?
WntRx Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is WntRx Pharmaceuticals worth (valuation)?
Valuation information for WntRx Pharmaceuticals is not publicly available.
Can I buy WntRx Pharmaceuticals stock?
WntRx Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was WntRx Pharmaceuticals's last funding round?
WntRx Pharmaceuticals's most recent funding round was Accelerator on February 29, 2016.
Who are the main investors in WntRx Pharmaceuticals?
Key investors in WntRx Pharmaceuticals include Harvard Innovation Labs, TSV Capital.
Will WntRx Pharmaceuticals IPO soon?
No public IPO plans have been announced for WntRx Pharmaceuticals.
How can I track WntRx Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WntRx Pharmaceuticals's secondary market activity and sign up for updates.